A menu-driven facility for sample-size calculation in multiarm, multistage randomized controlled trials with time-to-event outcomes: Update

被引:12
作者
Bratton, Daniel J. [1 ]
Choodari-Oskooei, Babak [1 ]
Royston, Patrick [1 ]
机构
[1] UCL, MRC Clin Trials Unit, London, England
基金
英国医学研究理事会;
关键词
st0175_1; nstage; nstagemenu; multiarm; multistage; randomized controlled trial; survival analysis; time-to-event; familywise error rate; CLINICAL-TRIALS; OVARIAN-CANCER; OF-BENEFIT; DESIGN; STAMPEDE;
D O I
10.1177/1536867X1501500202
中图分类号
O1 [数学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 0701 ; 070101 ;
摘要
Barthel, Royston, and Parmar (2009, Stata Journal 9: 505-523) presented a menu-driven Stata program for calculating sample size and other design characteristics for a class of multiarm, multistage trials with time-to-event outcomes. In this article, we present several new features for the package. First, we allow hazard ratios greater than 1 to be targeted under the alternative hypothesis to make the design more widely applicable to other outcomes and disease areas. Second, we introduce new subroutines that use simulation to more accurately estimate the correlation between treatment effects at different stages and that calculate the familywise error rate, and we apply them to an example using the original design of the multiarm, multistage trial in prostate cancer. Finally,. we present a new design of the dialog menu for nstage that improves its usability and incorporates options for calling the new subroutines.
引用
收藏
页码:350 / 368
页数:19
相关论文
共 17 条
[1]  
[Anonymous], 2002, Technical report
[2]  
Barthel F. M.-S., 2006, THESIS U COLL LONDON
[3]   A menu-driven facility for sample-size calculation in novel multiarm, multistage randomized controlled trials with a time-to-event outcome [J].
Barthel, Friederike M-S. ;
Royston, Patrick ;
Parmar, Mahesh K. B. .
STATA JOURNAL, 2009, 9 (04) :505-523
[4]   A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis [J].
Bratton, Daniel J. ;
Phillips, Patrick P. J. ;
Parmar, Mahesh K. B. .
BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
[5]   Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome [J].
Choodari-Oskooei, Babak ;
Parmar, Mahesh K. B. ;
Royston, Patrick ;
Bowden, Jack .
TRIALS, 2013, 14
[7]   A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection [J].
Magirr, D. ;
Jaki, T. ;
Whitehead, J. .
BIOMETRIKA, 2012, 99 (02) :494-501
[8]   Speeding up the evaluation of new agents in cancer [J].
Parmar, Mahesh K. B. ;
Barthel, Friederike M. -S. ;
Sydes, Matthew ;
Langley, Ruth ;
Kaplan, Rick ;
Eisenhauer, Elizabeth ;
Brady, Mark ;
James, Nicholas ;
Bookman, Michael A. ;
Swart, Ann-Marie ;
Qian, Wendi ;
Royston, Patrick .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (17) :1204-1214
[9]   An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse [J].
Phillips, Patrick P. J. ;
Fielding, Katherine ;
Nunn, Andrew J. .
PLOS ONE, 2013, 8 (05)
[10]   Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer [J].
Raja, F. A. ;
Griffin, C. L. ;
Qian, W. ;
Hirte, H. ;
Parmar, M. K. ;
Swart, A. M. ;
Ledermann, J. A. .
BRITISH JOURNAL OF CANCER, 2011, 105 (07) :884-889